Literature DB >> 23773010

An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation.

Seika Nakamura1, Reika Wate, Satoshi Kaneko, Hidefumi Ito, Mitsuaki Oki, Ayako Tsuge, Masato Nagashima, Shinya Asayama, Kengo Fujita, Masataka Nakamura, Hirofumi Maruyama, Hideshi Kawakami, Hirofumi Kusaka.   

Abstract

A 64-year-old man noticed weakness in his arms and dyspnea upon exertion. Four months later he was admitted to our hospital, where muscle atrophy and hyperactive deep tendon reflexes in the arms were observed upon examination. A needle electromyograph study revealed acute and chronic denervation in the extremities, and he was diagnosed as having amyotrophic lateral sclerosis (ALS). Seven months after onset of the disease, he died of respiratory failure. Neuropathologically, neuronal cell loss was observed in the motor cortex, hypoglossal nuclei, cervical and lumbar anterior horns and Clarke's nuclei. Some of the remaining neurons contained neurofilamentous conglomerate inclusions (CIs). A small number of Lewy body-like hyaline inclusions (LBHIs) were also observed. No the Bunina bodies, skein-like inclusions or basophilic inclusions were detectable. Tract degeneration was moderate in the dorsal and ventral spinocerebellar tracts, mild in the pyramidal tract, but not discerned in the posterior column. Immunohistochemical examinations revealed that the CIs were strongly positive for phosphorylated neurofilament and moderately positive for ubiquitin and Cu/Zn superoxide dismutase 1 (SOD1). Moreover, a number of phosphorylated tau protein-positive globose neurofibrillary tangles (NFTs) and threads were observed in the periaqueductal gray matter, oculomotor nuclei and trochlear nuclei. Although the family history was negative for neuromuscular diseases, the neuropathological findings indicated features of familial ALS with a SOD1 mutation. In fact, DNA analysis of frozen-brain tissue revealed the presence of the I113TSOD1 mutation. This case represents the first one of this mutation in a patient who showed CIs as well as LBHIs in the motor neurons at the same time, in addition to the NFTs in the mesencephalic tegmentum.
© 2013 Japanese Society of Neuropathology.

Entities:  

Keywords:  Lewy body-like hyaline inclusion; familial amyotrophic lateral sclerosis; neurofibrillary tangle; neurofilamentous conglomerate inclusion; sporadic amyotrophic lateral sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23773010     DOI: 10.1111/neup.12049

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  12 in total

Review 1.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

2.  An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Authors:  Grant Coan; Cassie S Mitchell
Journal:  Neurodegener Dis       Date:  2015-07-16       Impact factor: 2.977

3.  Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis.

Authors:  Tiziana Petrozziello; Evan A Bordt; Alexandra N Mills; Spencer E Kim; Ellen Sapp; Benjamin A Devlin; Abigail A Obeng-Marnu; Sali M K Farhan; Ana C Amaral; Simon Dujardin; Patrick M Dooley; Christopher Henstridge; Derek H Oakley; Andreas Neueder; Bradley T Hyman; Tara L Spires-Jones; Staci D Bilbo; Khashayar Vakili; Merit E Cudkowicz; James D Berry; Marian DiFiglia; M Catarina Silva; Stephen J Haggarty; Ghazaleh Sadri-Vakili
Journal:  Mol Neurobiol       Date:  2021-11-10       Impact factor: 5.682

4.  Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS.

Authors:  Barış Genç; Javier H Jara; Amiko K B Lagrimas; Peter Pytel; Raymond P Roos; M Marsel Mesulam; Changiz Geula; Eileen H Bigio; P Hande Özdinler
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

5.  Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review.

Authors:  QianQian Wei; QingQing Zhou; YongPing Chen; RuWei Ou; Bei Cao; YaQian Xu; Jing Yang; Hui-Fang Shang
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 6.  Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.

Authors:  Alexander J Moszczynski; Matthew A Hintermayer; Michael J Strong
Journal:  Front Neurosci       Date:  2018-04-20       Impact factor: 4.677

7.  Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models.

Authors:  Keith Crosby; Anthony M Crown; Brittany L Roberts; Hilda Brown; Jacob I Ayers; David R Borchelt
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

8.  Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis.

Authors:  Anthony M Crown; Brittany L Roberts; Keith Crosby; Hilda Brown; Jacob I Ayers; P John Hart; David R Borchelt
Journal:  G3 (Bethesda)       Date:  2019-03-07       Impact factor: 3.154

9.  Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.

Authors:  Anthony Crown; Luke McAlary; Eric Fagerli; Hilda Brown; Justin J Yerbury; Ahmad Galaleldeen; Neil R Cashman; David R Borchelt; Jacob I Ayers
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

10.  Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.

Authors:  Hung-Jin Huang; Tung-Ti Chang; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.